Stifel Reiterates Buy Rating on Evolus (EOLS)

Go back to Stifel Reiterates Buy Rating on Evolus (EOLS)

Evolus (EOLS) Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue

January 21, 2025 8:04 AM EST

Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today announced its preliminary, unaudited net revenue for the fourth quarter and full-year ended December 31, 2024. The preliminary unaudited results described in this press release are based on the most current information available to management... More